Mode
Text Size
Log in / Sign up
N/A N=145 Randomized Single-blind Treatment

Trauma Informed Guilt Reduction Therapy

Guilt · Shame · Post-traumatic Stress Disorders

Enrolled (actual)
145
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Trauma Related Guilt Inventory - Guilt Severity — 2.5; 2.5; 1.6; 2.2 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Trauma Informed Guilt Reduction Therapy (Behavioral); Supportive Care Therapy (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Veterans Medical Research Foundation
Primary completion
Jun 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Trauma Related Guilt Inventory - Guilt Severity
2.5; 2.5; 1.6; 2.2
SECONDARY
Change in Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale - 5 (CAPS-5)
38.2; 38.6; 23.3; 30.9
SECONDARY
Change in Patient Health Questionnaire - 9 (PHQ-9)
15.1; 14.4; 9.8; 12.5
SECONDARY
Change in Internalized Shame Scale
51.4; 49.6; 37.4; 41.9
SECONDARY
Change in World Health Organization Quality of Life - Brief
43.7; 44.5; 48.3; 44.4
SECONDARY
Change in Brief Symptom Inventory-18
53.1; 54.0; 47.3; 49.0

Summary

The goal of this project is to determine if a 6-session psychotherapy intervention will help Veterans feel less deployment-related guilt and less distress related to their guilt. Half of the participants will receive the guilt focused intervention and half will receive a supportive intervention. A supplemental pilot study added in FY2021 will examine the intervention for pandemic-related guilt events.

Eligibility Criteria

Inclusion Criteria

  • Participant Served in OEF/OIF/OND, has post-traumatic guilt related to deployment event (for pandemic supplement in 2021, has guilt related to pandemic event)

Exclusion Criteria

  • Moderate or severe cognitive impairment, acute suicidality, current severe substance use disorder, unmanaged psychosis or mania
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02512445). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search